Caroline Phan

Ms. Caroline Phan

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
ESEleanor C. Semmes
Eleanor C. Semmes
IMItzayana Guadalupe Miller
Itzayana Guadalupe Miller
NRNicole Rodgers
Nicole Rodgers
CPCaroline Phan
Caroline Phan
JHJillian H. Hurst
Jillian H. Hurst
SPSallie Permar
Sallie Permar
Human cytomegalovirus (HCMV) is the most common vertically transmitted infection worldwide, yet there are no vaccines or therapeutics to prevent congenital HCMV (cCMV) infection. Emerging evidence indicates that antibody Fc effector functions may be a previously underappreciated component of maternal immunity against HCMV. We recently reported that antibody-dependent cellular phagocytosis (ADCP) and IgG activation of FcγRI/FcγRII were associated with protection against cCMV transmission, leading us to hypothesize that additional Fc-mediated antibody functions may be important. In this same cohort of HCMV-transmitting ( n = 41) and nontransmitting ( n = 40) mother-infant dyads, we report that higher maternal sera antibody–dependent cellular cytotoxicity (ADCC) activation is also associated with lower risk of cCMV transmission. We investigated the relationship between ADCC and IgG responses against 9 viral antigens and found that ADCC activation correlated most strongly with sera IgG binding to the HCMV immunoevasin protein UL16. Moreover, we determined that higher UL16-specific IgG binding and FcγRIII/CD16 engagement were associated with the greatest risk reduction in cCMV transmission. Our findings indicate that ADCC-activating antibodies against targets such as UL16 may represent an important protective maternal immune response against cCMV infection that can guide future HCMV correlates studies and vaccine or antibody-based therapeutic development.

29 September 2026 in Viruses
Verified
Journal Article
Open access
PDF file
EMEllie Mainou
Ellie Mainou
SBStella Joan Berendam
Stella Joan Berendam
VOVeronica Obregon-Perko
Veronica Obregon-Perko
EREmilie Russell
Emilie Russell
CPCaroline Phan
Caroline Phan
JCJessica M. Conway
Jessica M. Conway
Viral dynamics of acute HIV infection and HIV rebound following suspension of antiretroviral therapy may be qualitatively similar but must differ given, for one, the development of adaptive immune responses. Understanding the differences between acute HIV infection and viral rebound dynamics in pediatric populations may provide insights into the mechanisms of viral control with potential implications for vaccine design and the development of effective targeted therapeutics for infants and children. Mathematical models have been a crucial tool to elucidate the complex processes driving viral infections within the host. Traditionally, acute HIV infection has been modeled with the standard model of viral dynamics, initially developed to explore viral decay during treatment, while viral rebound has necessitated extensions of that standard model to incorporate explicit immune responses. Previous efforts to fit these models to viral load data have underscored differences between the two infection stages, such as increased viral clearance rate and increased death rate of infected cells during rebound. However, these findings have been predicated on viral load measurements from disparate adult individuals. In this study, we aim to bridge this gap, in infants, by comparing the dynamics of acute infection and viral rebound within the same individuals by leveraging an infant non-human primate Simian/Human Immunodeficiency Virus (SHIV) infection model. Ten infant Rhesus macaques (RMs) orally challenged with SHIV.C.CH505.375H.dCT were given ART at 8 weeks post-infection. These infants were monitored for up to 60 weeks post-infection to ensure full suppression, then underwent analytic treatment interruption (ATI), resulting in viral rebound. We use the HIV standard viral dynamics model fit to viral load measurements in a nonlinear mixed effects framework to identify primary mechanisms distinguishing acute and rebound infection dynamics. We find that the primary difference between acute infection and viral rebound is the increased death rate of infected cells during the rebound phase. These findings allow us to formulate hypotheses about the effects of adaptive immune responses. Specifically, we propose that delayed viral rebound is characterized by a stronger CD8+ T-cell response. Our analysis provides evidence to support this notion and helps elucidate the observed outcomes.